Cas:173336-98-6 (R)-5-Aminomethyl-pyrrolidin-2-one manufacturer & supplier

Chemical Name:(R)-5-Aminomethyl-pyrrolidin-2-one

CAS.NO:173336-98-6

Synonyms:(5R)-5-(aminomethyl)pyrrolidin-2-one;2-Pyrrolidinone, 5-(aminomethyl)-, (5R)-;(R)-5-Aminomethyl-pyrrolidin-2-one;(5R)-5-(Aminomethyl)-2-pyrrolidinone

Molecular Formula:C₅H₁₀N₂O

Molecular Weight:114.146

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:313.9±15.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.481

PSA:55.12000

Exact Mass:114.079315

LogP:-2.44

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (5R)-5-(aminomethyl)pyrrolidin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(5R)-5-(Aminomethyl)-2-pyrrolidinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5R)-5-(aminomethyl)pyrrolidin-2-one Use and application,(R)-5-Aminomethyl-pyrrolidin-2-one technical grade,usp/ep/jp grade.

Related News: The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. (R)-5-Aminomethyl-pyrrolidin-2-one manufacturer Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,�� said Mark Corbett, EVP, Inceptua Medicines Access. (R)-5-Aminomethyl-pyrrolidin-2-one supplier The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. (R)-5-Aminomethyl-pyrrolidin-2-one vendor These include: high-barrier generic drug substances and commonly used generic drug substances. (R)-5-Aminomethyl-pyrrolidin-2-one factory The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.